Theratechnologies Inc T.TH

Oups

[Stephber]

+18%

[Bucknelly21]

Lol and gone 

[Bucknelly21]

If cydy announced this they would be up 30% lol yet like normal anything positive big or small get ignored and mostly ends up dragging on the price.

[PWIB123]

The selling pressure continues no matter the news. This is ridiculous, but I don't think the IV push was really ever going to be a catalyst. This does continue to reinforce everything we've discussed here.

[stephanedodier]

I am not sure that it's the selling pressure or the lack of interest, the volume is low...   

[SPCEO1]

Volume is actually pretty good for THTX, at least, for the first hour and fifteen minutes of trading. The trading this morning int he pre-market was certainly weird  but the stock is now back at even versus yesterday, which makes sense since this news today is not really market moving info. And while the stock has been lower in Q3, it is worth remembering that the "selling pressure"

[Wino115]

Price needs something more significant. Don't expect much until human data on projects starts coming through.  By the way, anyone else notice that this is the first PR I can recall where it only has Leah as the contact.  They've ditched Denis Boucher as head of PR being listed.  Perhaps a sign that is where some of the issues in communications and PR came from?

[SPCEO1]

Good eye! While I hope Mr. Boucher has not been let go as I never like to see someone lose their job, some of the screw-ups have been pretty bad. Perhaps the two press releases never making it to the wire services were the last straw with him? Also, I thought I should pass this along. The NBF analyst put out a short note on the news on IV Push today, which makes sense. What doesn't make sense

[Wino115]

You're right about the analyst. Tin-hat time at NBF!  Maybe Boucher is just doing the regulatory communication portion and not the market facing elements. He's done a modest job at getting some media coverage, but if oncology develops in to something they really need to push the PR button with more mass media outlets to spread the news and create some buzz both in the cancer field but

[SPCEO1]

You are absolutely correct about that. I hope TH is adequately preparing for an extensive PR effort if they do have good results in cancer. If the analysts will not lead the charge, then perhaps then can at least follow as they get swept up in a PR-led swarm of nterest in TH's cancer drug.